Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial
Abstract Background Viral load (VL) testing is key in monitoring adherence to antiretroviral therapy (ART) and documenting HIV treatment response. As per HIV treatment guidelines in Uganda, the first VL test is recommended 6 months after initiation of ART. Undetectable VL (uVL) at ART initiation may...
Main Authors: | Grace Gabagaya, Gordon Rukundo, Alexander Amone, Priscilla Wavamunno, Joyce Namale-Matovu, Irene Lubega, Clemensia Nakabiito, Zikulah Namukwaya, Monica Nolan, Samuel S. Malamba, Rachel King, Jaco Homsy, Mary Glenn Fowler, Philippa Musoke |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-021-06608-4 |
Similar Items
-
Enhanced peer-group strategies to support the prevention of mother-to-child HIV transmission leads to increased retention in care in Uganda: A randomized controlled trial.
by: Alexander Amone, et al.
Published: (2024-01-01) -
Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda
by: Rita Nakalega, et al.
Published: (2020-10-01) -
Enterovirus D68 in Viet Nam (2009-2015) [version 1; referees: 2 approved, 1 approved with reservations]
by: Nguyen Thi Han Ny, et al.
Published: (2017-06-01) -
In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus [version 2; referees: 2 approved]
by: Jaspreet Jain, et al.
Published: (2017-12-01) -
Analysis of HIV RNA Results in HIV/AIDS Patients
by: Kadriye Kart Yaşar, et al.
Published: (2014-06-01)